SCHEMBL9890439

SCHEMBL9890439

c1cc(-c2ccc3oc4ccc5c6cc(-n7c8ccccc8c8ccccc87)ccc6oc5c4c3c2)cc(-c2ccc3oc4ccc5c6cc(-n7c8ccccc8c8ccccc87)ccc6oc5c4c3c2)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 4/20 0.36
PLA2G4A P47712 4/20 0.36
PLA2G10 O15496 1/20 0.36
KDM4E B2RXH2 3/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
ATM Q13315 1/20 0.34
PRKDC P78527 1/20 0.33
ALOX5 P09917 1/20 0.33
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32
ALDH1A1 P00352 2/20 0.32
HSD17B10 Q99714 2/20 0.32
POLB P06746 1/20 0.32
TSHR P16473 1/20 0.32
BRCA1 P38398 1/20 0.32
PTPRF P10586 3/20 0.32
PTPN2 P17706 3/20 0.32
PTPN1 P18031 3/20 0.32
MAPT P10636 2/20 0.31
HPGD P15428 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9890391 0.98 PLA2G2A (0.38) PLA2G2APLA2G4APLA2G10KDM4EL3MBTL1
SCHEMBL9890394 0.98 PLA2G2A (0.38) PLA2G2APLA2G4APLA2G10KDM4EL3MBTL1
SCHEMBL9890441 0.97 KDM4E (0.36) PLA2G2APLA2G4APLA2G10KDM4EL3MBTL1
SCHEMBL9890387 0.96 KDM4E (0.36) PLA2G2APLA2G4APLA2G10KDM4EL3MBTL1
SCHEMBL9890396 0.96 PLA2G2A (0.37) PLA2G2APLA2G4APLA2G10KDM4EL3MBTL1
SCHEMBL9890432 0.96 KDM4E (0.37) PLA2G2APLA2G4APLA2G10KDM4EL3MBTL1
SCHEMBL9890393 0.95 PLA2G2A (0.38) PLA2G2APLA2G4APLA2G10KDM4EL3MBTL1
SCHEMBL9890405 0.95 PLA2G2A (0.38) PLA2G2APLA2G4APLA2G10KDM4EL3MBTL1
SCHEMBL9890401 0.95 PLA2G2A (0.38) PLA2G2APLA2G4APLA2G10KDM4EL3MBTL1
SCHEMBL9890425 0.95 KDM4E (0.36) PLA2G2APLA2G4APLA2G10KDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-01-24 US disclosed
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-01-24 US disclosed
US-8318323-B2 Polycyclic compounds and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2012-11-27 US disclosed
US-8318323-B2 Polycyclic compounds and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2012-11-27 US disclosed
US-20120138915-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-07 US disclosed
US-20120138915-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-07 US disclosed
US-20100012931-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2010-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME KCNC1, EED, BMI1 PLA2G2A 4239/4885PLA2G4A 4728/4885PLA2G10 4642/4885
US-20100012931-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME KCNC1, EED, BMI1 PLA2G2A 4239/4885PLA2G4A 4728/4885PLA2G10 4642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.